New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
Read more at The New York Times
-
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.Business - CNBC - 3 days ago -
Even with access to blockbuster obesity drugs, some people don't lose weight
Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant poundsHealth - ABC News - 6 days ago -
Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...Health - ABC News - 3 days ago -
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...Business - MarketWatch - 4 days ago -
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by ...Health - ABC News - 3 days ago -
Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses ...Top stories - CBS News - 3 days ago -
What the early voting data shows about new voters — a group that could swing the election
With nearly 60 million ballots already cast, everyone interested in the presidential election is trying to figure out where the race stands.Politics - NBC News - November 1 -
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the researchHealth - ABC News - October 31 -
How to help your dog lose weight and stay healthy
More than half of American dogs are overweight or obese – a condition that could shorten their lifespan. CBS News' Nikki Battiste shares the wellness journey of IAMS spokesdog Waylon and highlights ...Top stories - CBS News - 3 days ago -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.Business - CNBC - November 13 -
Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms
Amgen’s MariTide achieved up to 20% weight loss in a mid-stage trial, but analysts were expecting up to 25%.Business - MarketWatch - 3 days ago -
French say ‘non’ for longer as data shows increase in age to lose virginity
Figures also reveal both men and women having less sex – but number of partners over lifetime increasing. The French have a certain reputation when it comes to the vie d’amour . But the latest ...World - The Guardian - November 15 -
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.Top stories - CBS News - 5 days ago -
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.Science - The New York Times - November 14 -
Who gets weight loss drugs covered by insurance? In North Carolina, being on Medicaid helps.
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended coverage for Medicaid recipients.Top stories - NBC News - 2 days ago -
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.Business - MarketWatch - 1 hour ago -
Biden proposes Medicare, Medicaid coverage of obesity drugs
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans. Millions of Americans ...Politics - The Hill - 4 days ago -
Biden proposes anti-obesity drug rule
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover obesity drugs A proposed rule from the Biden administration would ...Politics - The Hill - 3 days ago -
New inflation data shows increase, days after election
Inflation accelerated in October, snapping a streak of six consecutive months of cooling inflation.Top stories - ABC News - November 13 -
New White House rule would make weight loss drugs available for people on Medicare and Medicaid
A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. ...Top stories - CBS News - 3 days ago -
Early 2025 Fantasy Baseball Rankings: Top 20 at catcher shows Yainer Diaz, Cal Raleigh among the standouts
This past season represented a big step back for what seemed like a position on the riseSports - CBS Sports - November 14 -
Cancer patient in Wales denied life-extending drug
Rachel Davies is not able to access the life-extending drug because she lives in Wales.Top stories - BBC News - November 15 -
Manchester City lose against Bournemouth as early-game struggles finally catch up with Pep Guardiola's team
After a string of Premier League comebacks, a two-goal deficit at Bournemouth was too much despite late pressureSports - CBS Sports - November 2 -
Nurse’s death linked to approved weight-loss drug
Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.Top stories - BBC News - November 8 -
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.Top stories - CBS News - November 3 -
'I thought I'd die after injecting black market anti-obesity drug'
Paige Roberts was left needing hospital treatment after injections made her vomit for 48 hours.Top stories - BBC News - November 21 -
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.Top stories - The New York Times - 3 days ago -
Biden proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.Top stories - ABC News - 3 days ago -
Democrats pick up House seat in New York as Williams loses to Mannion
Democratic state Sen. John Mannion defeated incumbent GOP Rep. Brandon Williams, flipping his upstate New York district. Williams swept into office on New York’s “red wave” in 2022 but was ...Politics - The Hill - November 6
More from The New York Times
-
Ms. Rachel, YouTube Star, Is Creating a Holiday Toy Frenzy
Business - The New York Times - 23 hours ago -
Will the Markets Check Trump’s Power?
Business - The New York Times - Yesterday -
Stocks Resume Post-Election Rise
Business - The New York Times - 22 hours ago -
Canada Accuses Google of Creating Advertising Tech Monopoly
Business - The New York Times - Yesterday -
Are Airline Loyalty Programs Worth It?
Business - The New York Times - 2 days ago